Celecoxib and Tasigna drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celecoxib (celecoxib) and Tasigna (nilotinib hydrochloride monohydrate). Common drug interactions include nodule among females and muscular weakness among males.

The phase IV clinical study analyzes what interactions people have when they take Celecoxib and Tasigna. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Celecoxib?

Celecoxib has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 38,217 Celecoxib users. Check the latest studies of Celecoxib.

What is Tasigna?

Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 31,535 Tasigna users. Check the latest studies of Tasigna.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

25 people who take Celecoxib and Tasigna together, and have interactions are studied.

Celecoxib and Tasigna drug interactions.

What are the common drug interactions of Celecoxib and Tasigna, by gender? *:

female:

Nodule (a growth of abnormal tissue)
Photophobia (extreme sensitivity to light)
Pruritus (severe itching of the skin)
Urticaria (rash of round, red welts on the skin that itch intensely)
Weight decreased
Weight increased
Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
Dementia (madness)
Chills (felling of cold)
Febrile neutropenia (fever with reduced white blood cells)

male:

Muscular weakness (muscle weakness)
Myalgia (muscle pain)
Abscess (pus)
Back disorder
Back pain
Basophil count increased
Bone deformity
Bone tuberculosis
Decreased appetite
Dyspepsia (indigestion)

What are the common drug interactions of Celecoxib and Tasigna, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Neoplasm progression (growth of tumour)

40-49:

n/a

50-59:

Visual impairment

60+:

Contusion (a type of hematoma of tissue in which capillaries)
Arthralgia (joint pain)
Aortic disorder
Blood glucose increased
Blood magnesium increased
Blood potassium increased
Blood urea increased
Bone callus excessive (excessive bony deposit formed between and around the broken ends of bone fractures)
Femur fracture
Flatulence (flatus expelled through the anus)

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 22 people, 88.00%
Insomnia (sleeplessness): 6 people, 24.00%
High Blood Pressure: 5 people, 20.00%
Back Pain: 5 people, 20.00%
Type 2 Diabetes: 4 people, 16.00%
Productive Cough: 4 people, 16.00%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 4 people, 16.00%
Cough: 4 people, 16.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 16.00%
Arrhythmias (irregular heartbeat): 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Celecoxib and Tasigna?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously